0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liver AI-assisted Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-5Z17324
Home | Market Reports | Health| Health Conditions
Global Liver AI assisted Diagnosis Market Research Report 2024
BUY CHAPTERS

Global Liver AI-assisted Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5Z17324
Report
November 2025
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Liver AI-assisted Diagnosis Market

The global Liver AI-assisted Diagnosis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Liver AI-assisted Diagnosis leading manufacturers including NANO-X, Sense Time, Shukun, VoxelCloud, G K Healthcare, GE HealthCare, zyheal, PathAI, Human Metabolomics lnstitute, ASTRI, etc., dominate supply; the top five capture approximately % of global revenue, with NANO-X leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Liver AI-assisted Diagnosis market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Liver AI-assisted Diagnosis Market Report

Report Metric Details
Report Name Liver AI-assisted Diagnosis Market
Segment by Type
  • Cloud-based
  • On-Primes
Segment by Application
  • Hospital
  • Clinic
  • Imaging Center
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NANO-X, Sense Time, Shukun, VoxelCloud, G K Healthcare, GE HealthCare, zyheal, PathAI, Human Metabolomics lnstitute, ASTRI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Liver AI-assisted Diagnosis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Liver AI-assisted Diagnosis Market report?

Ans: The main players in the Liver AI-assisted Diagnosis Market are NANO-X, Sense Time, Shukun, VoxelCloud, G K Healthcare, GE HealthCare, zyheal, PathAI, Human Metabolomics lnstitute, ASTRI

What are the Application segmentation covered in the Liver AI-assisted Diagnosis Market report?

Ans: The Applications covered in the Liver AI-assisted Diagnosis Market report are Hospital, Clinic, Imaging Center

What are the Type segmentation covered in the Liver AI-assisted Diagnosis Market report?

Ans: The Types covered in the Liver AI-assisted Diagnosis Market report are Cloud-based, On-Primes

1 Study Coverage
1.1 Introduction to Liver AI-assisted Diagnosis: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Liver AI-assisted Diagnosis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cloud-based
1.2.3 On-Primes
1.3 Market Segmentation by Application
1.3.1 Global Liver AI-assisted Diagnosis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Imaging Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Liver AI-assisted Diagnosis Revenue Estimates and Forecasts 2020-2031
2.2 Global Liver AI-assisted Diagnosis Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Liver AI-assisted Diagnosis Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Liver AI-assisted Diagnosis Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cloud-based Market Size by Players
3.3.2 On-Primes Market Size by Players
3.4 Global Liver AI-assisted Diagnosis Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Liver AI-assisted Diagnosis Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Liver AI-assisted Diagnosis Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Liver AI-assisted Diagnosis Market Size by Type (2020-2031)
6.4 North America Liver AI-assisted Diagnosis Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Liver AI-assisted Diagnosis Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Liver AI-assisted Diagnosis Market Size by Type (2020-2031)
7.4 Europe Liver AI-assisted Diagnosis Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Liver AI-assisted Diagnosis Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Liver AI-assisted Diagnosis Market Size by Type (2020-2031)
8.4 Asia-Pacific Liver AI-assisted Diagnosis Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Liver AI-assisted Diagnosis Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Liver AI-assisted Diagnosis Market Size by Type (2020-2031)
9.4 Central and South America Liver AI-assisted Diagnosis Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Liver AI-assisted Diagnosis Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Liver AI-assisted Diagnosis Market Size by Type (2020-2031)
10.4 Middle East and Africa Liver AI-assisted Diagnosis Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Liver AI-assisted Diagnosis Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 NANO-X
11.1.1 NANO-X Corporation Information
11.1.2 NANO-X Business Overview
11.1.3 NANO-X Liver AI-assisted Diagnosis Product Features and Attributes
11.1.4 NANO-X Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.1.5 NANO-X Liver AI-assisted Diagnosis Revenue by Product in 2024
11.1.6 NANO-X Liver AI-assisted Diagnosis Revenue by Application in 2024
11.1.7 NANO-X Liver AI-assisted Diagnosis Revenue by Geographic Area in 2024
11.1.8 NANO-X Liver AI-assisted Diagnosis SWOT Analysis
11.1.9 NANO-X Recent Developments
11.2 Sense Time
11.2.1 Sense Time Corporation Information
11.2.2 Sense Time Business Overview
11.2.3 Sense Time Liver AI-assisted Diagnosis Product Features and Attributes
11.2.4 Sense Time Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.2.5 Sense Time Liver AI-assisted Diagnosis Revenue by Product in 2024
11.2.6 Sense Time Liver AI-assisted Diagnosis Revenue by Application in 2024
11.2.7 Sense Time Liver AI-assisted Diagnosis Revenue by Geographic Area in 2024
11.2.8 Sense Time Liver AI-assisted Diagnosis SWOT Analysis
11.2.9 Sense Time Recent Developments
11.3 Shukun
11.3.1 Shukun Corporation Information
11.3.2 Shukun Business Overview
11.3.3 Shukun Liver AI-assisted Diagnosis Product Features and Attributes
11.3.4 Shukun Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.3.5 Shukun Liver AI-assisted Diagnosis Revenue by Product in 2024
11.3.6 Shukun Liver AI-assisted Diagnosis Revenue by Application in 2024
11.3.7 Shukun Liver AI-assisted Diagnosis Revenue by Geographic Area in 2024
11.3.8 Shukun Liver AI-assisted Diagnosis SWOT Analysis
11.3.9 Shukun Recent Developments
11.4 VoxelCloud
11.4.1 VoxelCloud Corporation Information
11.4.2 VoxelCloud Business Overview
11.4.3 VoxelCloud Liver AI-assisted Diagnosis Product Features and Attributes
11.4.4 VoxelCloud Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.4.5 VoxelCloud Liver AI-assisted Diagnosis Revenue by Product in 2024
11.4.6 VoxelCloud Liver AI-assisted Diagnosis Revenue by Application in 2024
11.4.7 VoxelCloud Liver AI-assisted Diagnosis Revenue by Geographic Area in 2024
11.4.8 VoxelCloud Liver AI-assisted Diagnosis SWOT Analysis
11.4.9 VoxelCloud Recent Developments
11.5 G K Healthcare
11.5.1 G K Healthcare Corporation Information
11.5.2 G K Healthcare Business Overview
11.5.3 G K Healthcare Liver AI-assisted Diagnosis Product Features and Attributes
11.5.4 G K Healthcare Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.5.5 G K Healthcare Liver AI-assisted Diagnosis Revenue by Product in 2024
11.5.6 G K Healthcare Liver AI-assisted Diagnosis Revenue by Application in 2024
11.5.7 G K Healthcare Liver AI-assisted Diagnosis Revenue by Geographic Area in 2024
11.5.8 G K Healthcare Liver AI-assisted Diagnosis SWOT Analysis
11.5.9 G K Healthcare Recent Developments
11.6 GE HealthCare
11.6.1 GE HealthCare Corporation Information
11.6.2 GE HealthCare Business Overview
11.6.3 GE HealthCare Liver AI-assisted Diagnosis Product Features and Attributes
11.6.4 GE HealthCare Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.6.5 GE HealthCare Recent Developments
11.7 zyheal
11.7.1 zyheal Corporation Information
11.7.2 zyheal Business Overview
11.7.3 zyheal Liver AI-assisted Diagnosis Product Features and Attributes
11.7.4 zyheal Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.7.5 zyheal Recent Developments
11.8 PathAI
11.8.1 PathAI Corporation Information
11.8.2 PathAI Business Overview
11.8.3 PathAI Liver AI-assisted Diagnosis Product Features and Attributes
11.8.4 PathAI Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.8.5 PathAI Recent Developments
11.9 Human Metabolomics lnstitute
11.9.1 Human Metabolomics lnstitute Corporation Information
11.9.2 Human Metabolomics lnstitute Business Overview
11.9.3 Human Metabolomics lnstitute Liver AI-assisted Diagnosis Product Features and Attributes
11.9.4 Human Metabolomics lnstitute Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.9.5 Human Metabolomics lnstitute Recent Developments
11.10 ASTRI
11.10.1 ASTRI Corporation Information
11.10.2 ASTRI Business Overview
11.10.3 ASTRI Liver AI-assisted Diagnosis Product Features and Attributes
11.10.4 ASTRI Liver AI-assisted Diagnosis Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Liver AI-assisted DiagnosisIndustry Chain Analysis
12.1 Liver AI-assisted Diagnosis Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Liver AI-assisted Diagnosis Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Liver AI-assisted Diagnosis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Liver AI-assisted Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Liver AI-assisted Diagnosis Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Liver AI-assisted Diagnosis Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Liver AI-assisted Diagnosis Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Liver AI-assisted Diagnosis Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Liver AI-assisted Diagnosis by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver AI-assisted Diagnosis as of 2024)
 Table 11. Global Liver AI-assisted Diagnosis Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Liver AI-assisted Diagnosis Companies Headquarters
 Table 13. Global Liver AI-assisted Diagnosis Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Liver AI-assisted Diagnosis Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Liver AI-assisted Diagnosis Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Liver AI-assisted Diagnosis Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Liver AI-assisted Diagnosis Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Liver AI-assisted Diagnosis High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Liver AI-assisted Diagnosis Growth Accelerators and Market Barriers
 Table 25. North America Liver AI-assisted Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Liver AI-assisted Diagnosis Growth Accelerators and Market Barriers
 Table 27. Europe Liver AI-assisted Diagnosis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Liver AI-assisted Diagnosis Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Liver AI-assisted Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Liver AI-assisted Diagnosis Investment Opportunities and Key Challenges
 Table 31. Central and South America Liver AI-assisted Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Liver AI-assisted Diagnosis Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Liver AI-assisted Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. NANO-X Corporation Information
 Table 35. NANO-X Description and Major Businesses
 Table 36. NANO-X Product Features and Attributes
 Table 37. NANO-X Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. NANO-X Revenue Proportion by Product in 2024
 Table 39. NANO-X Revenue Proportion by Application in 2024
 Table 40. NANO-X Revenue Proportion by Geographic Area in 2024
 Table 41. NANO-X Liver AI-assisted Diagnosis SWOT Analysis
 Table 42. NANO-X Recent Developments
 Table 43. Sense Time Corporation Information
 Table 44. Sense Time Description and Major Businesses
 Table 45. Sense Time Product Features and Attributes
 Table 46. Sense Time Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Sense Time Revenue Proportion by Product in 2024
 Table 48. Sense Time Revenue Proportion by Application in 2024
 Table 49. Sense Time Revenue Proportion by Geographic Area in 2024
 Table 50. Sense Time Liver AI-assisted Diagnosis SWOT Analysis
 Table 51. Sense Time Recent Developments
 Table 52. Shukun Corporation Information
 Table 53. Shukun Description and Major Businesses
 Table 54. Shukun Product Features and Attributes
 Table 55. Shukun Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Shukun Revenue Proportion by Product in 2024
 Table 57. Shukun Revenue Proportion by Application in 2024
 Table 58. Shukun Revenue Proportion by Geographic Area in 2024
 Table 59. Shukun Liver AI-assisted Diagnosis SWOT Analysis
 Table 60. Shukun Recent Developments
 Table 61. VoxelCloud Corporation Information
 Table 62. VoxelCloud Description and Major Businesses
 Table 63. VoxelCloud Product Features and Attributes
 Table 64. VoxelCloud Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. VoxelCloud Revenue Proportion by Product in 2024
 Table 66. VoxelCloud Revenue Proportion by Application in 2024
 Table 67. VoxelCloud Revenue Proportion by Geographic Area in 2024
 Table 68. VoxelCloud Liver AI-assisted Diagnosis SWOT Analysis
 Table 69. VoxelCloud Recent Developments
 Table 70. G K Healthcare Corporation Information
 Table 71. G K Healthcare Description and Major Businesses
 Table 72. G K Healthcare Product Features and Attributes
 Table 73. G K Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. G K Healthcare Revenue Proportion by Product in 2024
 Table 75. G K Healthcare Revenue Proportion by Application in 2024
 Table 76. G K Healthcare Revenue Proportion by Geographic Area in 2024
 Table 77. G K Healthcare Liver AI-assisted Diagnosis SWOT Analysis
 Table 78. G K Healthcare Recent Developments
 Table 79. GE HealthCare Corporation Information
 Table 80. GE HealthCare Description and Major Businesses
 Table 81. GE HealthCare Product Features and Attributes
 Table 82. GE HealthCare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. GE HealthCare Recent Developments
 Table 84. zyheal Corporation Information
 Table 85. zyheal Description and Major Businesses
 Table 86. zyheal Product Features and Attributes
 Table 87. zyheal Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. zyheal Recent Developments
 Table 89. PathAI Corporation Information
 Table 90. PathAI Description and Major Businesses
 Table 91. PathAI Product Features and Attributes
 Table 92. PathAI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. PathAI Recent Developments
 Table 94. Human Metabolomics lnstitute Corporation Information
 Table 95. Human Metabolomics lnstitute Description and Major Businesses
 Table 96. Human Metabolomics lnstitute Product Features and Attributes
 Table 97. Human Metabolomics lnstitute Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Human Metabolomics lnstitute Recent Developments
 Table 99. ASTRI Corporation Information
 Table 100. ASTRI Description and Major Businesses
 Table 101. ASTRI Product Features and Attributes
 Table 102. ASTRI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. ASTRI Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Liver AI-assisted Diagnosis Product Picture
 Figure 2. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Cloud-based Product Picture
 Figure 4. On-Primes Product Picture
 Figure 5. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Imaging Center
 Figure 9. Liver AI-assisted Diagnosis Report Years Considered
 Figure 10. Global Liver AI-assisted Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Liver AI-assisted Diagnosis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Liver AI-assisted Diagnosis Revenue Market Share by Region (2020-2031)
 Figure 14. Global Liver AI-assisted Diagnosis Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Cloud-based Revenue Market Share by Player in 2024
 Figure 17. On-Primes Revenue Market Share by Player in 2024
 Figure 18. Global Liver AI-assisted Diagnosis Revenue Market Share by Type (2020-2031)
 Figure 19. Global Liver AI-assisted Diagnosis Revenue Market Share by Application (2020-2031)
 Figure 20. North America Liver AI-assisted Diagnosis Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Liver AI-assisted Diagnosis Revenue (US$ Million) in 2024
 Figure 22. North America Liver AI-assisted Diagnosis Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Liver AI-assisted Diagnosis Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Liver AI-assisted Diagnosis Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Liver AI-assisted Diagnosis Revenue (US$ Million) in 2024
 Figure 29. Europe Liver AI-assisted Diagnosis Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Liver AI-assisted Diagnosis Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 32. France Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Liver AI-assisted Diagnosis Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Liver AI-assisted Diagnosis Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Liver AI-assisted Diagnosis Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Liver AI-assisted Diagnosis Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 44. India Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Liver AI-assisted Diagnosis Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Liver AI-assisted Diagnosis Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Liver AI-assisted Diagnosis Revenue (US$ Million) in 2024
 Figure 52. Central and South America Liver AI-assisted Diagnosis Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Liver AI-assisted Diagnosis Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Liver AI-assisted Diagnosis Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Liver AI-assisted Diagnosis Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Liver AI-assisted Diagnosis Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Liver AI-assisted Diagnosis Revenue (US$ Million) in 2024
 Figure 58. South America Liver AI-assisted Diagnosis Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Liver AI-assisted Diagnosis Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Liver AI-assisted Diagnosis Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Liver AI-assisted Diagnosis Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Liver AI-assisted Diagnosis Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Liver AI-assisted Diagnosis Revenue (2020-2025) & (US$ Million)
 Figure 64. Liver AI-assisted Diagnosis Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart